Somerset, TX, United States of America

James E Burdett, Jr

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James E Burdett, Jr: Innovator in Pharmaceutical Chemistry

Introduction

James E Burdett, Jr. is a notable inventor based in Somerset, Texas, who has made significant contributions to the field of pharmaceutical chemistry. His work primarily focuses on the preparation of complex chemical compounds that have important applications in medicine.

Latest Patents

James E Burdett, Jr. holds a patent for a method of preparing 17.alpha.-acetoxy-11.beta.-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione. This innovative process involves several steps, including protecting hydroxyl groups, reacting with alkali or alkaline earth metal anion radicals, hydrolyzing, ketalizing carbonyl groups, epoxidizing, and introducing functional groups. The detailed methodology showcases his expertise in synthesizing pharmaceutical compounds.

Career Highlights

Burdett's career is marked by his role at the United States of America as Represented by the Department of Health. His work has contributed to advancements in drug development and has implications for therapeutic applications.

Collaborations

Throughout his career, James E Burdett, Jr. has collaborated with esteemed colleagues such as Hyun K Kim and Pemmaraju Narasinha Rao. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

James E Burdett, Jr. exemplifies the spirit of innovation in pharmaceutical chemistry through his patented methods and collaborative efforts. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…